Iveda shareholders approve redomicile to Delaware; warrant issuance vote adjourned to June 2

Iveda Solutions, Inc.

Redomicile from Nevada to Delaware approved: 1,233,381 for, 21,273 against, 19,553 abstained.
Proposal 4 (increase authorized shares) no longer required given redomicile approval.
Proposal 5 (issuance of 625K Series A and 625K Series B warrants) did not pass; meeting adjourned to June 2, 2025, at 9:30 a.m. MT.
Adjourned meeting will be held at Iveda's offices in Mesa, AZ; quorum was 54.37% of outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.